NN 9904
Alternative Names: NN-9904; NN9904 – Once weekly oral semaLatest Information Update: 03 Feb 2023
At a glance
- Originator Novo Nordisk
- Class Antidementias; Antihyperglycaemics; Glucagon-like peptides; Hepatoprotectants; Obesity therapies; Urologics; Vascular disorder therapies
- Mechanism of Action Glucagon-like peptide-1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Diabetes mellitus